21 results on '"Brinc, Davor"'
Search Results
2. Immune Checkpoint Inhibitor-Associated Myocarditis With Persistent Troponin Elevation Despite Abatacept and Prolonged Immunosuppression
3. Performance evaluation of all analytes on the epoc® Blood Analysis System for use in hospital surgical and intensive care units
4. Precision of point of care glucose metre measurements in the context of neonatal hypoglycemia.
5. Semen biomarker TEX101 predicts sperm retrieval success for men with testicular failure
6. Evaluation of Dried Blood Spot Testing for SARS-CoV-2 Serology Using a Quantitative Commercial Assay
7. Intravenous immunoglobulin ameliorates ITP via activating Fc[gamma] receptors on dendritic cells
8. Changes in Cardiovascular Biomarkers Associated With the Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor Ertugliflozin in Patients With Chronic Kidney Disease and Type 2 Diabetes
9. Immunoglobulin G-mediated regulation of the murine immune response to transfused red blood cells occurs in the absence of active immune suppression: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the fetus and newborn?
10. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?
11. Neuronal pentraxin receptor-1 is a new cerebrospinal fluid biomarker of Alzheimer’s disease progression
12. MOESM2 of Identification of brain-enriched proteins in the cerebrospinal fluid proteome by LC-MS/MS profiling and mining of the Human Protein Atlas
13. Preclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertility
14. Identification of brain-enriched proteins in the cerebrospinal fluid proteome by LC-MS/MS profiling and mining of the Human Protein Atlas
15. Immunocapture-Selected Reaction Monitoring Screening Facilitates the Development of ELISA for the Measurement of Native TEX101 in Biological Fluids*
16. False Biomarker Discovery due to Reactivity of a Commercial ELISA for CUZD1 with Cancer Antigen CA125
17. Infection and Cancer: Revaluation of the Hygiene Hypothesis
18. Closing the Gaps in Pediatric Laboratory Reference Intervals: A CALIPER Database of 40 Biochemical Markers in a Healthy and Multiethnic Population of Children
19. Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn
20. IVIg-Primed Leukocytes Offer Longer Protection in the Amelioration of ITP Than IVIg.
21. Can IVIg Preparations with Specificity for Soluble Antigens Mimic the Therapeutic Effects of IVIg in the Treatment of Immune Thrombocytopenia?.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.